Oncoswab
1 known investors
OncoSwab develops a nasal swab-based sampling platform for detecting lung cancer biomarkers and circulating tumor DNA in airway-derived genetic material. The platform is designed for research use to enable earlier lung cancer detection and biomarker discovery by sampling at the anatomical origin of disease.
BiotechDigital HealthMedical Devices